PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
2019-01-01 Mariotti, F. R.; Petrini, S.; Ingegnere, T.; Tumino, N.; Besi, F.; Scordamaglia, F.; Munari, E.; Pesce, S.; Marcenaro, E.; Moretta, A.; Vacca, P.; Moretta, L.
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy
2020-01-01 Shibata, M.; Ooki, A.; Inokawa, Y.; Sadhukhan, P.; Ugurlu, M. T.; Izumchenko, E.; Munari, E.; Bogina, G.; Rudin, C. M.; Gabrielson, E.; Singh, A.; Hoque, M. O.
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
2020-01-01 Torlakovic, E.; Lim, H. J.; Adam, J.; Barnes, P.; Bigras, G.; Chan, A. W. H.; Cheung, C. C.; Chung, J. -H.; Couture, C.; Fiset, P. O.; Fujimoto, D.; Han, G.; Hirsch, F. R.; Ilie, M.; Ionescu, D.; Li, C.; Munari, E.; Okuda, K.; Ratcliffe, M. J.; Rimm, D. L.; Ross, C.; Røge, R.; Scheel, A. H.; Soo, R. A.; Swanson, P. E.; Tretiakova, M.; To, K. F.; Vainer, G. W.; Wang, H.; Xu, Z.; Zielinski, D.; Tsao, M. -S.
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
2020-01-01 Tumino, N.; Vacca, P.; Quatrini, L.; Munari, E.; Moretta, F.; Pelosi, A.; Mariotti, F. R.; Moretta, L.
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
2020-01-01 Mariotti, F. R.; Quatrini, L.; Munari, E.; Vacca, P.; Tumino, N.; Pietra, G.; Mingari, M. C.; Moretta, L.
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy
2020-01-01 Quatrini, L.; Mariotti, F. R.; Munari, E.; Tumino, N.; Vacca, P.; Moretta, L.
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets
2020-01-01 Caliò, A.; Brunelli, M.; Segala, D.; Pedron, S.; Remo, A.; Ammendola, S.; Munari, E.; Pierconti, F.; Mosca, A.; Bollito, E.; Sidoni, A.; Fisogni, S.; Sacco, C.; Canu, L.; Sentinelli, S.; Fraccon, A. P.; Fiorentino, M.; Scott, C.; Milella, M.; Porta, C.; Argani, P.; Martignoni, G.
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
2022-01-01 Tumino, N.; Besi, F.; Martini, S.; Di Pace, A. L.; Munari, E.; Quatrini, L.; Pelosi, A.; Fiore, P. F.; Fiscon, G.; Paci, P.; Scordamaglia, F.; Covesnon, M. G.; Bogina, G.; Mingari, M. C.; Moretta, L.; Vacca, P.
aCHAT-WF: Generating conversational agents for teaching business process models
2022-01-01 Rooein, D.; Bianchini, D.; Leotta, F.; Mecella, M.; Paolini, P.; Pernici, B.
Context-Based Resilience in Cyber-Physical Production System
2021-01-01 Bagozi, A.; Bianchini, D.; Antonellis, V. D.
Multi-level and relevance-based parallel clustering of massive data streams in smart manufacturing
2021-01-01 Bagozi, A.; Bianchini, D.; De Antonellis, V.
La validazione del contenuto informativo è la chiave del successo di un processo BIM-based
2015-01-01 Ciribini, ANGELO LUIGI CAMILLO; MASTROLEMBO VENTURA, Silvia; Bolpagni, Marzia
Client and User Involvement Through BIM- Related Technologies
2017-01-01 Mastrolembo Ventura, S.; Ciribini, A.
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy
2022-01-01 Corino, V. D. A.; Bologna, M.; Calareso, G.; Resteghini, C.; Sdao, S.; Orlandi, E.; Licitra, L.; Mainardi, L.; Bossi, P.
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
2022-01-01 Mcdowell, L.; Bossi, P.
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group
2022-01-01 Klinghammer, K.; Lorini, L.; Nevens, D.; Simon, C.; Machiels, J. -P.; Bossi, P.
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives
2022-01-01 Alberti, A.; Bossi, P.
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts
2022-01-01 Stanganelli, I.; Spagnolo, F.; Argenziano, G.; Ascierto, P. A.; Bassetto, F.; Bossi, P.; Donato, V.; Massi, D.; Massone, C.; Patuzzo, R.; Pellacani, G.; Quaglino, P.; Queirolo, P.; Zalaudek, I.; Palmieri, G.
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions
2022-01-01 Economopoulou, P.; Pantazopoulos, A.; Spathis, A.; Kotsantis, I.; Kyriazoglou, A.; Kavourakis, G.; Zakopoulou, R.; Chatzidakis, I.; Anastasiou, M.; Prevezanou, M.; Resteghini, C.; Licitra, L.; Bergamini, C.; Colombo, E.; Caspani, F.; Denaro, N.; Vecchio, S.; Bonomo, P.; Rocca, M. C.; Bertolini, F.; Ferrari, D.; Psyrri, A.; Bossi, P.
THz-photonics transceivers by all-dielectric phonon-polariton nonlinear nanoantennas
2022-01-01 Leon, Unai Arregui; Rocco, Davide; Carletti, Luca; Peccianti, Marco; Maci, Stefano; Della Valle, Giuseppe; De Angelis, Costantino
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression | 1-gen-2019 | Mariotti, F. R.; Petrini, S.; Ingegnere, T.; Tumino, N.; Besi, F.; Scordamaglia, F.; Munari, E.; Pesce, S.; Marcenaro, E.; Moretta, A.; Vacca, P.; Moretta, L. | |
| Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy | 1-gen-2020 | Shibata, M.; Ooki, A.; Inokawa, Y.; Sadhukhan, P.; Ugurlu, M. T.; Izumchenko, E.; Munari, E.; Bogina, G.; Rudin, C. M.; Gabrielson, E.; Singh, A.; Hoque, M. O. | |
| “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy | 1-gen-2020 | Torlakovic, E.; Lim, H. J.; Adam, J.; Barnes, P.; Bigras, G.; Chan, A. W. H.; Cheung, C. C.; Chung, J. -H.; Couture, C.; Fiset, P. O.; Fujimoto, D.; Han, G.; Hirsch, F. R.; Ilie, M.; Ionescu, D.; Li, C.; Munari, E.; Okuda, K.; Ratcliffe, M. J.; Rimm, D. L.; Ross, C.; Røge, R.; Scheel, A. H.; Soo, R. A.; Swanson, P. E.; Tretiakova, M.; To, K. F.; Vainer, G. W.; Wang, H.; Xu, Z.; Zielinski, D.; Tsao, M. -S. | |
| Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? | 1-gen-2020 | Tumino, N.; Vacca, P.; Quatrini, L.; Munari, E.; Moretta, F.; Pelosi, A.; Mariotti, F. R.; Moretta, L. | |
| Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 | 1-gen-2020 | Mariotti, F. R.; Quatrini, L.; Munari, E.; Vacca, P.; Tumino, N.; Pietra, G.; Mingari, M. C.; Moretta, L. | |
| The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy | 1-gen-2020 | Quatrini, L.; Mariotti, F. R.; Munari, E.; Tumino, N.; Vacca, P.; Moretta, L. | |
| Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets | 1-gen-2020 | Caliò, A.; Brunelli, M.; Segala, D.; Pedron, S.; Remo, A.; Ammendola, S.; Munari, E.; Pierconti, F.; Mosca, A.; Bollito, E.; Sidoni, A.; Fisogni, S.; Sacco, C.; Canu, L.; Sentinelli, S.; Fraccon, A. P.; Fiorentino, M.; Scott, C.; Milella, M.; Porta, C.; Argani, P.; Martignoni, G. | |
| Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity | 1-gen-2022 | Tumino, N.; Besi, F.; Martini, S.; Di Pace, A. L.; Munari, E.; Quatrini, L.; Pelosi, A.; Fiore, P. F.; Fiscon, G.; Paci, P.; Scordamaglia, F.; Covesnon, M. G.; Bogina, G.; Mingari, M. C.; Moretta, L.; Vacca, P. | |
| aCHAT-WF: Generating conversational agents for teaching business process models | 1-gen-2022 | Rooein, D.; Bianchini, D.; Leotta, F.; Mecella, M.; Paolini, P.; Pernici, B. | |
| Context-Based Resilience in Cyber-Physical Production System | 1-gen-2021 | Bagozi, A.; Bianchini, D.; Antonellis, V. D. | |
| Multi-level and relevance-based parallel clustering of massive data streams in smart manufacturing | 1-gen-2021 | Bagozi, A.; Bianchini, D.; De Antonellis, V. | |
| La validazione del contenuto informativo è la chiave del successo di un processo BIM-based | 1-gen-2015 | Ciribini, ANGELO LUIGI CAMILLO; MASTROLEMBO VENTURA, Silvia; Bolpagni, Marzia | |
| Client and User Involvement Through BIM- Related Technologies | 1-gen-2017 | Mastrolembo Ventura, S.; Ciribini, A. | |
| Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy | 1-gen-2022 | Corino, V. D. A.; Bologna, M.; Calareso, G.; Resteghini, C.; Sdao, S.; Orlandi, E.; Licitra, L.; Mainardi, L.; Bossi, P. | |
| The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer? | 1-gen-2022 | Mcdowell, L.; Bossi, P. | |
| Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group | 1-gen-2022 | Klinghammer, K.; Lorini, L.; Nevens, D.; Simon, C.; Machiels, J. -P.; Bossi, P. | |
| Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives | 1-gen-2022 | Alberti, A.; Bossi, P. | |
| The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts | 1-gen-2022 | Stanganelli, I.; Spagnolo, F.; Argenziano, G.; Ascierto, P. A.; Bassetto, F.; Bossi, P.; Donato, V.; Massi, D.; Massone, C.; Patuzzo, R.; Pellacani, G.; Quaglino, P.; Queirolo, P.; Zalaudek, I.; Palmieri, G. | |
| Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions | 1-gen-2022 | Economopoulou, P.; Pantazopoulos, A.; Spathis, A.; Kotsantis, I.; Kyriazoglou, A.; Kavourakis, G.; Zakopoulou, R.; Chatzidakis, I.; Anastasiou, M.; Prevezanou, M.; Resteghini, C.; Licitra, L.; Bergamini, C.; Colombo, E.; Caspani, F.; Denaro, N.; Vecchio, S.; Bonomo, P.; Rocca, M. C.; Bertolini, F.; Ferrari, D.; Psyrri, A.; Bossi, P. | |
| THz-photonics transceivers by all-dielectric phonon-polariton nonlinear nanoantennas | 1-gen-2022 | Leon, Unai Arregui; Rocco, Davide; Carletti, Luca; Peccianti, Marco; Maci, Stefano; Della Valle, Giuseppe; De Angelis, Costantino |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista47996
Data di pubblicazione
- In corso di stampa77
- 2020 - 202714220
- 2010 - 201916686
- 2000 - 200910044
- 1990 - 19994739
- 1980 - 19891875
- 1970 - 1979350
- 1960 - 19694
- 1959 - 19591
Editore
- Elsevier BV:PO Box 211, 1000 AE A...269
- Lippincott, Williams & Wilkins:53...147
- Elsevier Science Limited:Oxford F...132
- Springer Verlag Germany:Tiergarte...112
- Giuffre Editore Spa:via Busto Ars...107
- American Institute of Physics:2 H...90
- Optical Society of America:2010 M...86
- Academic Press Incorporated:6277 ...78
- Edizioni Minerva Medica:Corso Bra...75
- Blackwell Science Limited:PO Box ...73
Rivista
- PHYSICS LETTERS. SECTION B377
- EUROPEAN JOURNAL OF HEART FAILURE262
- GIORNALE ITALIANO DI MEDICINA DEL...210
- JOURNAL OF HIGH ENERGY PHYSICS210
- PHYSICAL REVIEW LETTERS202
- SENSORS AND ACTUATORS. B, CHEMICAL199
- EFSA JOURNAL185
- PLOS ONE176
- JOURNAL OF CLINICAL MEDICINE172
- BLOOD167
Keyword
- Humans2748
- Male1285
- Female1270
- Middle Aged840
- Aged769
- Adult696
- COVID-19535
- Italy426
- Treatment Outcome348
- Nuclear and High Energy Physics339
Lingua
- eng38570
- ita7396
- fre130
- spa119
- enm41
- und29
- ger27
- por16
- chi4
- bul3
Accesso al fulltext
- no fulltext31374
- open7268
- reserved5940
- restricted3343
- partially open51
- embargoed15
- mixed5